Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results Burning Rock Biotech Limited Guangzhou, CHINA GUANGZHOU, China, March 10, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today reported financial results for the three months and year ended December 31, 2020. Recent Business Highlights Early Detection Completed product development of the 6-cancer test (training and validation data released in November 2020 at the ESMO Asia Virtual Congress). Capacity ramp-up under way for volume production. Early access programs initiated to gather real-world feedback, with preparation in progress for commercialization (targeted for 2022).